Marimastat (BB-2516) is a potent matrix metalloproteinase (MMP) and ADAM-17 inhibitor. It affects Notch and Rho/Rac1 signaling by blocking extracellular matrix degradation and specific protein cleavage, effectively inhibiting tumor invasion, angiogenesis, and snake venom-induced coagulopathy.